AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34232202 — intervention group
Group type: COMPARATOR
Intervention: Placebo (no magnetic field therapy)
Number of subjects: 38
Study 32955839 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic and core strength training (PCST) program, 8 weeks, twice/week
Number of subjects: 29
Study 32955839 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG), normal training without additional pelvic and core strengthening
Number of subjects: 29
Study 35657948 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular depot medroxyprogesterone acetate
Number of subjects: 5768
Study 35657948 — intervention group
Group type: EXPERIMENTAL
Intervention: Copper intrauterine device
Number of subjects: 5768
Study 35657948 — intervention group
Group type: EXPERIMENTAL
Intervention: Levonorgestrel implant
Number of subjects: 5768
Study 34394913 — intervention group
Group type: EXPERIMENTAL
Intervention: Bufei Huoxue (BFHX) capsules
Number of subjects: 0
Study 34394913 — intervention group
Group type: COMPARATOR
Intervention: Control group (routine treatment)
Number of subjects: 0
Study 32629035 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiviral therapy (90.9% acyclovir, 6.2% ganciclovir, 2.9% both)
Number of subjects: 306
Study 32629035 — intervention group
Group type: COMPARATOR
Intervention: Control (no antiviral therapy)
Number of subjects: 306
Study 35431897 — intervention group
Group type: EXPERIMENTAL
Intervention: IERMS-based intervention for 12 weeks
Number of subjects: 120
Study 35431897 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 120
Study 35190566 — intervention group
Group type: EXPERIMENTAL
Intervention: PPSF with pointed lotus-style regulator (Group C)
Number of subjects: 60
Study 35190566 — intervention group
Group type: EXPERIMENTAL
Intervention: PPSF with flat end lotus-style regulator (Group B)
Number of subjects: 60
Study 35190566 — intervention group
Group type: COMPARATOR
Intervention: Traditional PPSF (Group A)
Number of subjects: 60
Study 35190566 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (A, B, C)
Number of subjects: 60
Study 33259452 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flow nasal oxygenation (HFNO)
Number of subjects: 34
Study 33259452 — intervention group
Group type: COMPARATOR
Intervention: Standard facemask (SFM)
Number of subjects: 34
Study 35833805 — intervention group
Group type: EXPERIMENTAL
Intervention: Aflibercept monotherapy (2.0 mg intravitreous)
Number of subjects: 312
Study 35833805 — intervention group
Group type: COMPARATOR
Intervention: Bevacizumab first (1.25 mg intravitreous)
Number of subjects: 312
Study 34528239 — intervention group
Group type: EXPERIMENTAL
Intervention: rhTPO 300 u/kg for 2 weeks
Number of subjects: 96
Study 34528239 — intervention group
Group type: COMPARATOR
Intervention: eltrombopag 25 mg/day for 2 weeks
Number of subjects: 96
Study 34528239 — intervention group
Group type: EXPERIMENTAL
Intervention: rhTPO 300 u/kg
Number of subjects: 96
Study 34528239 — intervention group
Group type: COMPARATOR
Intervention: eltrombopag 25 mg/day
Number of subjects: 96
Study 34528239 — intervention group
Group type: EXPERIMENTAL
Intervention: rhTPO and eltrombopag
Number of subjects: 96
Study 35738236 — intervention group
Group type: EXPERIMENTAL
Intervention: Convolutional Neural Network (CNN) model using whole axial brain T2-weighted MR images
Number of subjects: 1233
Study 32962657 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 18
Study 32962657 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane
Number of subjects: 18
Study 33921952 — intervention group
Group type: EXPERIMENTAL
Intervention: Back School Postural Education Program (GA) - three sessions of 45 min each, at intervals of 1 week.
Number of subjects: 153
Study 33921952 — intervention group
Group type: COMPARATOR
Intervention: Back School Postural Education Program (GB) - one theoretical session of 90 min for all students.
Number of subjects: 153
Study 33415861 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined acupuncture-medicine anesthesia
Number of subjects: 60
Study 33415861 — intervention group
Group type: COMPARATOR
Intervention: Intravenous anesthesia
Number of subjects: 60
Study 33342328 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured pre-visit planning intervention
Number of subjects: 280
Study 33342328 — intervention group
Group type: COMPARATOR
Intervention: Standard reminder call (Control)
Number of subjects: 280
Study 34166299 — intervention group
Group type: EXPERIMENTAL
Intervention: Ayahuasca
Number of subjects: 17
Study 34166299 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 35904293 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-immunogenic staphylokinase (NS)
Number of subjects: 336
Study 35904293 — intervention group
Group type: COMPARATOR
Intervention: Alteplase (A)
Number of subjects: 336
Study 33675794 — intervention group
Group type: EXPERIMENTAL
Intervention: COVID-19 infection
Number of subjects: 1856
Study 33675794 — intervention group
Group type: EXPERIMENTAL
Intervention: Early COVID-19 infection (before 32 weeks gestation)
Number of subjects: 1856
Study 33675794 — intervention group
Group type: EXPERIMENTAL
Intervention: Late COVID-19 infection (after 32 weeks gestation)
Number of subjects: 1856
Study 33675794 — intervention group
Group type: COMPARATOR
Intervention: Control group (women with negative SARS-CoV-2 test)
Number of subjects: 1856
Study 33244202 — intervention group
Group type: EXPERIMENTAL
Intervention: High-risk group based on DNA methylation classification
Number of subjects: 0
Study 33244202 — intervention group
Group type: COMPARATOR
Intervention: Low-risk group based on DNA methylation classification
Number of subjects: 0
Study 35954713 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% CHX gel
Number of subjects: 38
Study 35954713 — intervention group
Group type: COMPARATOR
Intervention: 0.12% CHX solution
Number of subjects: 38
Study 34644228 — intervention group
Group type: EXPERIMENTAL
Intervention: NOMAC‐E2
Number of subjects: 101498
Study 34644228 — intervention group
Group type: COMPARATOR
Intervention: COCLNG
Number of subjects: 101498
Study 33150743 — intervention group
Group type: EXPERIMENTAL
Intervention: Obesogenic medications
Number of subjects: 5145
Study 35855954 — intervention group
Group type: EXPERIMENTAL
Intervention: sGDNF in CHB patients with fibrosis (28.4 pg/ml)
Number of subjects: 735
Study 35855954 — intervention group
Group type: EXPERIMENTAL
Intervention: sGDNF in CHB patients with cirrhosis (33.8 pg/ml)
Number of subjects: 735
Study 35855954 — intervention group
Group type: EXPERIMENTAL
Intervention: sGDNF diagnostic accuracy
Number of subjects: 735
Study 35855954 — intervention group
Group type: EXPERIMENTAL
Intervention: sGDNF-high group
Number of subjects: 735
Study 35855954 — intervention group
Group type: EXPERIMENTAL
Intervention: sGDNF
Number of subjects: 735
Study 34482050 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular training (n = 13 participants)
Number of subjects: 32
Study 34482050 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care (n = 14 participants)
Number of subjects: 32
Study 36123929 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid artery stenting
Number of subjects: 0
Study 36123929 — intervention group
Group type: COMPARATOR
Intervention: Medication alone
Number of subjects: 0
Study 33929807 — intervention group
Group type: EXPERIMENTAL
Intervention: Clareon IOL
Number of subjects: 40
Study 33929807 — intervention group
Group type: COMPARATOR
Intervention: AcrySof IQ IOL
Number of subjects: 40
Study 32851809 — intervention group
Group type: EXPERIMENTAL
Intervention: Venglustat l‐malate (2, 5, 15, 25, 50, 100, or 150 mg) single oral dose
Number of subjects: 0
Study 32851809 — intervention group
Group type: EXPERIMENTAL
Intervention: Venglustat l‐malate (5, 10, or 20 mg) repeated once‐daily oral doses for 14 days
Number of subjects: 0
Study 32851809 — intervention group
Group type: EXPERIMENTAL
Intervention: Venglustat l‐malate
Number of subjects: 0
Study 32851809 — intervention group
Group type: EXPERIMENTAL
Intervention: Venglustat
Number of subjects: 0
Study 32296197 — intervention group
Group type: EXPERIMENTAL
Intervention: Concomitant chemoradiotherapy with temozolamide after two cycles of standard chemotherapy (Group-B)
Number of subjects: 64
Study 32296197 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy alone (Group-A)
Number of subjects: 64
Study 36424680 — intervention group
Group type: EXPERIMENTAL
Intervention: QFR-guided strategy (PCI performed only if QFR ≤0.80)
Number of subjects: 3825
Study 36424680 — intervention group
Group type: COMPARATOR
Intervention: Angiography-guided strategy
Number of subjects: 3825
Study 36424680 — intervention group
Group type: EXPERIMENTAL
Intervention: QFR-guided strategy
Number of subjects: 3825
Study 34218071 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention based on virtual clinical simulation and problem‐based learning using the Diagnostician Nurse software
Number of subjects: 32
Study 34218071 — intervention group
Group type: COMPARATOR
Intervention: Conventional class on clinical reasoning skills (Control)
Number of subjects: 32
Study 33861669 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultra-modified internal sphincterotomy (UMIS)
Number of subjects: 200
Study 33861669 — intervention group
Group type: COMPARATOR
Intervention: Closed lateral internal sphincterotomy (CLIS)
Number of subjects: 200
Study 32608151 — intervention group
Group type: EXPERIMENTAL
Intervention: 755 nm picosecond Alexandrite laser treatment
Number of subjects: 16
Study 32608151 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 16
Study 36178833 — intervention group
Group type: EXPERIMENTAL
Intervention: Cancer-frame version of the questionnaire
Number of subjects: 1803
Study 36178833 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptom-frame version of the questionnaire
Number of subjects: 1803
Study 36178833 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall response rate
Number of subjects: 1803
Study 36178833 — intervention group
Group type: COMPARATOR
Intervention: Comparison of response rates based on wording
Number of subjects: 1803
Study 36178833 — intervention group
Group type: COMPARATOR
Intervention: Regional GPs
Number of subjects: 1803
Study 34032389 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive diabetes treatment (inpatient treatment for 2 weeks)
Number of subjects: 61
Study 32822260 — intervention group
Group type: EXPERIMENTAL
Intervention: 45 minutes of fixed, moderate-intensity cycling followed by an incremental ride to exhaustion
Number of subjects: 21
Study 32822260 — intervention group
Group type: EXPERIMENTAL
Intervention: 45 minutes of fixed, moderate-intensity cycling
Number of subjects: 21
Study 32822260 — intervention group
Group type: COMPARATOR
Intervention: Sham capsule
Number of subjects: 21
Study 32822260 — intervention group
Group type: EXPERIMENTAL
Intervention: Longer duration exercise (up to 45 min)
Number of subjects: 21
Study 32822260 — intervention group
Group type: EXPERIMENTAL
Intervention: HI/EE performed following a sustained bout of dehydrating activity
Number of subjects: 21
Study 35598024 — intervention group
Group type: EXPERIMENTAL
Intervention: lecanemab, an anti-Aβ protofibril antibody
Number of subjects: 0
Study 32139485 — intervention group
Group type: EXPERIMENTAL
Intervention: Tele-continuous EEG (tele-cEEG)
Number of subjects: 0
Study 32139485 — intervention group
Group type: COMPARATOR
Intervention: Tele-routine EEG (Tele-rEEG)
Number of subjects: 0
Study 32139485 — intervention group
Group type: EXPERIMENTAL
Intervention: Tele-cEEG
Number of subjects: 0
Study 33668304 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based telerehabilitation based on 200 m fast walking test (200 mFWT)
Number of subjects: 19
Study 34490952 — intervention group
Group type: EXPERIMENTAL
Intervention: Predictive models for hip/femur fractures
Number of subjects: 270000
Study 34490952 — intervention group
Group type: EXPERIMENTAL
Intervention: Predictive models for major osteoporotic fractures
Number of subjects: 270000
Study 32636283 — intervention group
Group type: EXPERIMENTAL
Intervention: Occupational advice intervention
Number of subjects: 66
Study 36271942 — intervention group
Group type: COMPARATOR
Intervention: ACE inhibitor (enalapril)
Number of subjects: 48
Study 36271942 — intervention group
Group type: COMPARATOR
Intervention: Placebo (CaCO3)
Number of subjects: 48
Study 32978751 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise + Amino Acid Supplementation
Number of subjects: 130
Study 32978751 — intervention group
Group type: COMPARATOR
Intervention: Exercise + Placebo Supplementation
Number of subjects: 130
Study 33514787 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride-free hydroxyapatite toothpaste (used three times daily)
Number of subjects: 207
Study 33514787 — intervention group
Group type: COMPARATOR
Intervention: Fluoride toothpaste (control group)
Number of subjects: 207
Study 33514787 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride-free hydroxyapatite toothpaste
Number of subjects: 207
Study 33261642 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpha lipoic acid (ALA)
Number of subjects: 17
Study 33261642 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 36122608 — intervention group
Group type: EXPERIMENTAL
Intervention: IoT-assisted TIGER
Number of subjects: 18
Study 36122608 — intervention group
Group type: COMPARATOR
Intervention: Task-specific motor training (TSMT)
Number of subjects: 18
Study 34414946 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing intervention measures
Number of subjects: 136
Study 34414946 — intervention group
Group type: COMPARATOR
Intervention: Routine nursing (Control)
Number of subjects: 136
Study 35848716 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity program based on intelligent wearable devices (N = 47)
Number of subjects: 143
Study 35848716 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based modified behavioral activation program (N = 48)
Number of subjects: 143
Study 35848716 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (N = 48)
Number of subjects: 143
Study 34226217 — intervention group
Group type: EXPERIMENTAL
Intervention: Subclinical LVD
Number of subjects: 337
Study 34226217 — intervention group
Group type: EXPERIMENTAL
Intervention: Abnormal LARS
Number of subjects: 337
Study 34226217 — intervention group
Group type: EXPERIMENTAL
Intervention: Subclinical AF
Number of subjects: 337
Study 34226217 — intervention group
Group type: EXPERIMENTAL
Intervention: MoCA score consistent with MCI
Number of subjects: 337
Study 34226217 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-adherence to AF screening
Number of subjects: 337
Study 34226217 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivariable logistic regression
Number of subjects: 337
Study 34226217 — intervention group
Group type: EXPERIMENTAL
Intervention: Subclinical AF and cardiac dysfunction
Number of subjects: 337
Study 34751632 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive change strategies for Black patients
Number of subjects: 218
Study 34751632 — intervention group
Group type: EXPERIMENTAL
Intervention: Validation strategies for Black patients
Number of subjects: 218
Study 34751632 — intervention group
Group type: EXPERIMENTAL
Intervention: Time spent on cognitive change strategies
Number of subjects: 218
Study 34751632 — intervention group
Group type: EXPERIMENTAL
Intervention: Time spent on validation strategies
Number of subjects: 218
Study 34751632 — intervention group
Group type: EXPERIMENTAL
Intervention: Importance of validation strategies
Number of subjects: 218
Study 34751632 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive racial attitudes among therapists
Number of subjects: 218
Study 34118916 — intervention group
Group type: EXPERIMENTAL
Intervention: Housing First + supportive services (n=120)
Number of subjects: 240
Study 34118916 — intervention group
Group type: COMPARATOR
Intervention: Supportive services alone (n=120)
Number of subjects: 240
Study 32393252 — intervention group
Group type: EXPERIMENTAL
Intervention: Evolocumab 420 mg Q4W for 16 weeks
Number of subjects: 30
Study 32393252 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 33938832 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol + Normal saline (PS)
Number of subjects: 40
Study 33938832 — intervention group
Group type: COMPARATOR
Intervention: Propofol + Dexmedetomidine (PD)
Number of subjects: 40
Study 32216762 — intervention group
Group type: EXPERIMENTAL
Intervention: gPM+ intervention
Number of subjects: 480
Study 32216762 — intervention group
Group type: COMPARATOR
Intervention: Enhanced treatment as usual
Number of subjects: 480
Study 35905657 — intervention group
Group type: EXPERIMENTAL
Intervention: MED diet plus whole fresh eggs (1 whole egg/1000 kcal; MED+E)
Number of subjects: 39
Study 35905657 — intervention group
Group type: EXPERIMENTAL
Intervention: MED diet without whole eggs (MED‐E)
Number of subjects: 39
Study 35905657 — intervention group
Group type: COMPARATOR
Intervention: Control American diet (AAD)
Number of subjects: 39
Study 32604422 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile force platform KMP (Motosana) measuring maximum force, power, and balance.
Number of subjects: 63
Study 32604422 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile force platform KMP (Motosana) measuring one leg standing without holding, transient help, or permanent holding at armrests.
Number of subjects: 63
Study 32949779 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal transcranial direct current stimulation (tDCS) at 1 mA for 15 minutes
Number of subjects: 3
Study 32949779 — intervention group
Group type: EXPERIMENTAL
Intervention: Cathodal transcranial direct current stimulation (tDCS)
Number of subjects: 3
Study 32949779 — intervention group
Group type: COMPARATOR
Intervention: Sham transcranial direct current stimulation (tDCS)
Number of subjects: 3
Study 36105381 — intervention group
Group type: EXPERIMENTAL
Intervention: BUZZY device with anesthetic gel
Number of subjects: 30
Study 36105381 — intervention group
Group type: COMPARATOR
Intervention: Cold alone with anesthetic gel
Number of subjects: 30
Study 33200887 — intervention group
Group type: EXPERIMENTAL
Intervention: GSK3640254 (1-700 mg)
Number of subjects: 78
Study 33200887 — intervention group
Group type: EXPERIMENTAL
Intervention: GSK3640254
Number of subjects: 78
Study 33200887 — intervention group
Group type: EXPERIMENTAL
Intervention: GSK3640254 mesylate salt
Number of subjects: 78
Study 33200887 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study 36114460 — intervention group
Group type: EXPERIMENTAL
Intervention: Opioid-containing anesthesia (OCA) with fentanyl
Number of subjects: 40
Study 36114460 — intervention group
Group type: COMPARATOR
Intervention: Opioid-free anesthesia (OFA)
Number of subjects: 40
Study 34039414 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 0
Study 34039414 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32757065 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate-protein solution (CHO-P; 0.8 g carbohydrate kg BM-1 + 0.8 g protein kg BM-1)
Number of subjects: 25
Study 32757065 — intervention group
Group type: COMPARATOR
Intervention: Carbohydrate (CHO; 1.6 g per kg body mass)
Number of subjects: 25
Study 32757065 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (CHO and CHO-P)
Number of subjects: 25
Study 32757065 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate-protein solution (CHO-P)
Number of subjects: 25
Study 32757065 — intervention group
Group type: COMPARATOR
Intervention: Carbohydrate (CHO)
Number of subjects: 25
Study 34260829 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal conbercept (IVC)
Number of subjects: 157
Study 34260829 — intervention group
Group type: COMPARATOR
Intervention: Sham IVC
Number of subjects: 157
Study 34521655 — intervention group
Group type: EXPERIMENTAL
Intervention: No arterial catheter insertion until absolutely needed (less invasive intervention)
Number of subjects: 1010
Study 34521655 — intervention group
Group type: COMPARATOR
Intervention: Systematic arterial catheter insertion in the early hours of shock (usual care)
Number of subjects: 1010
Study 34473389 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-completed survey measuring skin cancer risk factors
Number of subjects: 238
Study 34473389 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-completed survey measuring sun exposure
Number of subjects: 238
Study 34473389 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-completed survey measuring treatment of skin cancers
Number of subjects: 238
Study 32116211 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacologic treatment
Number of subjects: 915
Study 32116211 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical exercise
Number of subjects: 915
Study 32116211 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychotherapy
Number of subjects: 915
Study 32116211 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet
Number of subjects: 915
Study 32116211 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapy
Number of subjects: 915
Study 32116211 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 915
Study 32116211 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of non-pharmacologic and pharmacologic therapies
Number of subjects: 915
Study 35488182 — intervention group
Group type: EXPERIMENTAL
Intervention: Salvage radiotherapy (SRT)
Number of subjects: 137
Study 35488182 — intervention group
Group type: EXPERIMENTAL
Intervention: Regional nodal/distant metastasis on PSMA-PET
Number of subjects: 137
Study 35488182 — intervention group
Group type: EXPERIMENTAL
Intervention: Salvage radiotherapy (SRT) with regional/distant metastasis on PSMA-PET
Number of subjects: 137
Study 35488182 — intervention group
Group type: EXPERIMENTAL
Intervention: Salvage radiotherapy (SRT) with EAU high-risk status
Number of subjects: 137
Study 35488182 — intervention group
Group type: COMPARATOR
Intervention: EAU high-risk status
Number of subjects: 137
Study 35488182 — intervention group
Group type: EXPERIMENTAL
Intervention: Regional/distant metastasis on PSMA-PET in EAU high-risk group
Number of subjects: 137
Study 34509775 — intervention group
Group type: EXPERIMENTAL
Intervention: Nightly medication use with standard-dose zolpidem (QHS)
Number of subjects: 55
Study 34509775 — intervention group
Group type: COMPARATOR
Intervention: Intermittent dosing with standard-dose zolpidem and placebos (IDwP)
Number of subjects: 55
Study 34509775 — intervention group
Group type: EXPERIMENTAL
Intervention: Continued QHS full dose treatment (FD/FD)
Number of subjects: 55
Study 34509775 — intervention group
Group type: COMPARATOR
Intervention: Intermittent dosing with standard-dose zolpidem and placebos (FD/VD)
Number of subjects: 55
Study 34509775 — intervention group
Group type: COMPARATOR
Intervention: Intermittent dosing with placebos (VD/VD)
Number of subjects: 55